0001654954-21-006531.txt : 20210602 0001654954-21-006531.hdr.sgml : 20210602 20210602161149 ACCESSION NUMBER: 0001654954-21-006531 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210601 FILED AS OF DATE: 20210602 DATE AS OF CHANGE: 20210602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cittadine Andrew CENTRAL INDEX KEY: 0001863624 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 21989231 MAIL ADDRESS: STREET 1: C/O 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2021-06-01 0001645469 Monopar Therapeutics MNPR 0001863624 Cittadine Andrew 1000 SKOKIE BLVD, STE 350 WILMETTE IL 60091 true Chief Operating Officer Stock Options 5.76 2021-06-01 4 A false 70000 0 A 2031-05-31 Common Stock 70000 70000 D Options vest 6/48ths on November 30, 2021 and 1/48th monthly on the last day of each month thereafter. /s/ Kim R. Tsuchimoto, Attorney-in-Fact 2021-06-02